Katri Rosenthal-Aizman

Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide.

Ű. Langel, M. Hällbrink, Yang Jiang, 2006, Biochemical pharmacology.

An improved synthesis of releasable luciferin–CPP conjugates

Ü. Langel, Emelía Eiríksdóttir, Katri Rosenthal-Aizman, 2009 .

Cell-penetrating peptides: a comparative membrane toxicity study.

Maria Lindgren, Ulo Langel, Mats Hansen, 2005, Analytical biochemistry.

Pharmacodynamic synergy strictly dependent on the co-operative aggregation of enantiomers of cyclic peptides in the bacterial cell membrane.

M. Danielsson, G. Bergsson, Katri Rosenthal-Aizman, 2011, Bioorganic & medicinal chemistry letters.

Self-assembling peptide nanotubes from enantiomeric pairs of cyclic peptides with alternating D and L amino acid residues.

Gunnar Svensson, G. Svensson, Katri Rosenthal-Aizman, 2004, Journal of the American Chemical Society.

Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo

A. Metspalu, C. I. Smith, B. Lebleu, 2011, Nucleic acids research.

Novel Target for Peptide-Based Imaging and Treatment of Brain Tumors

Heikki Joensuu, Ale Närvänen, Ulo Langel, 2014, Molecular Cancer Therapeutics.

Models and Technologies Novel Target for Peptide-Based Imaging and Treatment of Brain Tumors

H. Joensuu, Ű. Langel, P. Laakkonen, 2014 .